Decarbonisation takes centre stage

Sustainable production and energy efficiency in the Life Sciences sector

Veolia is focusing on our solutions to help the pharmaceutical industry to reduce its carbon footprint and improve its sustainability at two events this week.

Future in Pharmaceuticals conference and exhibition 2024

At the Future in Pharmaceuticals conference and exhibition we showcased our range of decarbonisation solutions to representatives of the top pharmaceutical and life sciences companies in Ireland. Visitors to our stand used our Virtual Reality (VR) headsets to explore how we are helping industry in Ireland to meet their environmental targets in a sustainable way.

Improve energy performance with guaranteed savings
Harness additional revenue, by operating spare electrical generating capacity and selling exported electricity to the National Grid

Attendees at the conference discusses a number of critical topics including 

  • The Decarbonisation of Heat through Electrification

  • The Journey Towards Understanding your Scope 1, 2 & 3 Emissions

  • Enhancing Sustainability, Climate Action & Energy Efficiency


Green Awards 2024

The Green Awards recognise the extraordinary contribution and commitment that businesses and other other organisations across many sectors make to helping create a more sustainable future for Ireland. Veolia is proud to be associated with this great event once again this year.

The Green Awards showcase the leadership and innovation in Irish businesses to help reduce our water usage, minimise carbon emissions and increase recycling.

With our long history of working with the Life Sciences sector Veolia is delighted to sponsor the Green Life Sciences category. The finalists include AbbVie, APC & VLE Therapeutics, Boston Scientific Galway, Harmac Medical Products, MSD Ireland, Pfizer Newbridge and Takeda Ireland. All are leading examples of building a sustainable Life Sciences sector in Ireland.

Congratulations to all those shortlisted and especially to all of the winners.